Authors say limiting certain food additives may be an effective public health strategy to prevent diabetes. (HealthDay News) — Two widely consumed food additive mixtures may increase type 2 diabetes ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Largest number of cancers was projected to result from abdomen and pelvic CT in adults, reflecting 37 percent of those 103,000 cancers.

Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Residual cancer after neoadjuvant therapy predicts recurrence years later in men undergoing surgery for high-risk prostate cancer.

(HealthDay News) — Exposure time to antidepressants in adults is associated with a higher risk for sudden cardiac death (SCD), according to a study presented at the annual meeting of the European ...

A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & ...

High-intensity interval training was associated with improved glycemic control and cardiometabolic outcomes among patients with type 2 diabetes.

Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022.

By December 2023, 12.3% of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM ...